The Study of Lipofibroblasts Differentiation of CD90＋ and CD90－ Orbital Fibroblasts Subsets in Patients with TAO

GAN Lu, LUO Qing-li, TANG Fei. et al

Abstract

Divided orbital fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) into CD90＋ and CD90－ subsets respect to surface CD90 expression, then determined whether CD90＋ and/or CD90－ fibroblasts were capable of differentiating into lipofibroblasts. Methods Fibroblasts subset separation into CD90＋ and CD90－ subsets was accomplished by three to four rounds of magnetic bead selection, then treated with ３-isobutyl-1-lmethylxanthine (IBMX), insulin and dexamethasone which was an known inducer of the lipofibroblastic phenotype, then the cells were observed every day to find Lipid droplets. Oil red O staining were conducted at 5 d, 10 d, 15 d, 20 d and 25 d after inducing. The percent of lipofibroblasts were calculated. Results The ratio in fibroblast derived from extraocular muscles of differentiating into lipofibroblast is less than from connective/adipose tissue (P＋ fibroblast is less than CD90－ fibroblast (P＋ cells derived from extraocular miscles could not be induced to differentiate into lipofibroblast. The ratio in CD90－ fibroblast from connective/adipose tissue is highest (P－ connective/adipose tissue.

 

Keywords: Thyroid-associated ophthalmopathy, Orbital fibroblasts subsets, Lipofibroblast 

 

Full Text:

PDF


References


HEUFELDER AE. Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev Endocr Metab Disord, 2000,1(1-2): 87-95.

PENNEY DP. К ENG PC.DKRDAK S ,et al. Morphologic and functional characteristics of subpopulation of murine lung fibroblasts grown in vitro. Anat Rec.1992.232(3):432-443.

BERENSON CS. SMITH TJ. Human orbital fibroblasts in culture express ganglioside profiles distinct from those in dermal fibroblasts. J Clin Endocrinol Metab, 1995. 80 ( 9): 2668-2674.

KURIYAN AE, WOELLER CF, (V LOUGH LIN CW, et al. Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype. Invest Ophthalmol Vis Sci. 2013, 54 ( 12 ); 7370- 7377.

VALYASEVI RW. JYONOUCHI SC. DUTTON CM. et al. Effect of tumor necrosis factor-alpha. interferon-gamma. and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab, 2001, 86 (2): 903-908.

SORISKY A, PARDASANI D. GAGNON A, et al. Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J Clin Endocrinol Metab, 1996.81 (9):3428-3431.

FORBES G. GORMAN CA, BRENNAN MD, el ul. Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle. AJNR Am J Neuroradiol. 1986.7(4);651-656.

HIROMATSU Y, YANG D, BEDNARCZUK T. et al. Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metah.2000,85(3): 1194-1199.

GUNJI K. DE BELLIS A, LI AW. et al. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s; autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves ’ hyperthyroidism. J Clin Endocrinol Metab. 2000. 85 ( 4 ): 1641-1647.

PEYSTER RG. GINSBERG F. SILBER JH. et al. Exophthalmos caused by excessive fat; CT volumetric analysis and differential diagnosis. AJR Am J Roentgenol. 1986.146(3) :459-464.

GIANOUKAKIS AG. SMITH TJ. Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy. Curr Opin Endocrinol Diabetes Obes.2008. 15(5) :446-452.

CRISP M. STARKEY KJ. LANE C. et al. Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci. 2000. 41

CAWOODTJ. MORI ARTY P. OFARRELLY C. et al.The effects of tumour necrosis factor-alpha and interleukin 1 on an in vitro model of thyroid-associated ophthalmopathy, contrasting effects on adipogenesis. Eur J Endocrinol. 2006. 155(3):395-403.

FUKADA S. YAMAMOTO Y. SEGAWA M. et al. CD90 positive cells, an additional cell population, produce laminin alpha2 upon transplantation to dy (3k)/dy (3k) mice. Exp Cell Res. 2008.314 (1): 193-203.

DUDASJ. MANSUROGLU T. BATUSIC D . et al. Thy-1 is expressed in myofibroblasts but not found in hepatic stellate cells following liver injury. Histochem Cell Biol. 2009. 131 (1): 115-127.

KHOO TK. COENEN MJ. SCHIEFER AR. Et al. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves’ ophthalmopathy. Thyroid.2008.18

SMITH TJ. KOUMAS L. GAGNON A. et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab.2002.87( 1 ) =385-392.

GREGOIRE FM. Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med (Maywood). 2001 .226( 11): 997-1002.


Refbacks

  • There are currently no refbacks.